Results of a reevaluation of cardiovascular outcomes in the RECORD trial.

Mahaffey, Kenneth W; Hafley, Gail; Dickerson, Sheila; Burns, Shana; Tourt-Uhlig, Sandra; White, Jennifer; Newby, L Kristin; Komajda, Michel; McMurray, John; Bigelow, Robert; Home, Philip D; Lopes, Renato D

Mahaffey, Kenneth W; Hafley, Gail; Dickerson, Sheila; Burns, Shana; Tourt-Uhlig, Sandra; White, Jennifer; Newby, L Kristin; Komajda, Michel; McMurray, John; Bigelow, Robert; Home, Philip D; Lopes, Renato D.

Affiliation

Mahaffey KW; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. kenneth.mahaffey@dm.duke.edu

Am Heart J ; 166(2): 240-249.e1, 2013 Aug.

Article in En | MEDLINE | ID: mdl-23895806

Subject(s)

Hypoglycemic Agents/adverse effects; Mortality; Myocardial Infarction/chemically induced; Stroke/chemically induced; Thiazolidinediones/adverse effects; Diabetes Mellitus, Type 2/drug therapy; Follow-Up Studies; Humans; Hypoglycemic Agents/therapeutic use; Myocardial Infarction/epidemiology; Randomized Controlled Trials as Topic; Research Design; Rosiglitazone; Stroke/epidemiology; Thiazolidinediones/therapeutic use; United States; United States Food and Drug Administration

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Mortality / Stroke / Thiazolidinediones / Hypoglycemic Agents / Myocardial Infarction Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am Heart J Year: 2013 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google